The webinar will consider questions such as how practices can maintain turnover whilst sticking to the government and regulator guidelines, and how this can be done without compromising the customer experience.
Hosted by Past President of the British Veterinary Association Gudrun Ravetz, three additional veterinary business experts - Brian Faulkner, Alison Lambert and Alan Robinson - will come together to share their advice on how to minimise the impact that coronavirus has on the practice, the team and a practice’s clients.
Veterinary professionals can submit questions directly to the panel who will answer them during the live event.
To register for the webinar, visit the Boehringer www.boehringer-academy.co.uk.
The talk, which is sponsored by Supreme Petfoods, will be co-delivered by Craig Tessyman, who works alongside Molly as Exotics Veterinary Nurse Team Leader at Rutland House Veterinary Referrals.
The presentation will focus on the main aspects of emergency care, including best practice for managing these cases in first opinion practice.
Topics will include restoring and maintaining fluid balance, cardio-pulmonary resuscitation (CPR), analgesia options and the importance of appropriate monitoring.
Molly said: “The basic principles of emergency care apply to all species, but with small herbivores, rapid intervention is crucial as their delicate physiology can quickly spiral into crisis when they become unwell.
"In this session, Craig and I will share practical tips that vets and nurses can implement immediately, without requiring specialist equipment, to help manage these challenging cases.”
The sixty minute talk will start at 12.50pm in the Gallery Suite 3-4.
For those unable to attend the live event, a recorded version of the presentation will be available here: https://supremepetfoods.com/vet-zone/cpd-webinars-and-videos/
The Company of Animals, makers of behaviour and training products, has announced the launch of a new Product and Training DVD, designed to be screened in practice waiting rooms. The DVD features the entire range of products from Company of Animals, including its multi-award-winning dog training devices, being demonstrated by pet dogs and their owners. It is presented by Animal Psychologist and founder of The Company of Animals, Dr. Roger Mugford. The Company of Animals says that playing the DVD during opening hours will grab the attention of your customers, raise their awareness of already popular products, and educate them about new ones. This DVD is free and available to all veterinary retailers. To order the DVD or for more information see: http://www.companyofanimals.co.uk/
The British Veterinary Association has welcomed the European Commission's Action Plan on Antimicrobial resistance (AMR), launched yesterday on the eve of European Antibiotic Awareness Day.
The Action Plan sets out 12 actions:
However, the association has expressed concern that the Commission has given only qualified support for new antimicrobials for veterinary use. Carl Padgett, President of the BVA, said: "There is much to be applauded in this action plan. In particular the BVA supports the calls for more and better coordinated research, more responsible use of antimicrobials in human and veterinary medicine, and the development of diagnostic tools to quickly and accurately identify the right drug for the right bug.
"The use of antimicrobials in the treatment and control of animal diseases is essential and the BVA supports the strong messages in this plan. Any option for managing AMR must be firmly rooted in sound scientific assessment of the risk.
"While the report recognises the difficulties that have led to the hampering of research into new antimicrobials for veterinary use, we are concerned that there is only qualified support from the Commission for the development of these new medicines for animal use.
"Research into new antimicrobials should be supported in both human and veterinary medicine. We need to ensure the creation of a more predictable regulatory environment to encourage new products for animals to be brought to the market.
"Finally, while the BVA supports the need for a new regulatory framework any new regulations must not impede the ability of veterinary surgeons to prescribe and dispense medicines according to their clinical judgement."
Meanwhile, Jill Moss of the Bella Moss Foundation added her voice to those calling for responsible use of antibiotics, highlighting recent research from the Royal Veterinary College that has established a clear link between pets with MRSA infection and human hospital-associated MRSA. What is less widely recognised, she says, is that resistant bacteria can be passed from human to animal.
The charity is now calling on health and veterinary professionals to work together to achieve a reduction in resistant infections by raising awareness and promoting the responsible use of antibiotics.
To coincide with National Microchipping Month in June this year, Avid will update the details of any pet with an Avid microchip registered on the UK 24hr PETtrac microchip database free of charge, saving their owner £6 for a change of address and £12 for a change of ownership.
In addition, anyone who contacts the company via its website during June will also be entered into a prize draw to win one year's worth of free pet insurance.
To update registration details free of charge, visit www.petchipupdate.com (the update service activates in June), or call 0800 652 8977.
Any microchipper who would like a Pet Chip Update Campaign pack can send a request via www.petchipupdate.com or call the AVID MicroChip sales line on 0800 652 7 977.
Companion Care Vets has been named as one of The Sunday Times 100 Best Companies To Work For, the first veterinary organisation to receive the accolade.
Companion Care, which has 90 surgeries across the UK (the majority within Pets at Home stores) launched its joint venture partner model in 2001. The group received a "first class" one-star status from The Sunday Times, and was ranked at number 69 overall, a position determined by employee views, staff policies, processes and services.
Best Companies Accreditation is based around employee engagement and listed companies are noted for "excelling in every area throughout the workplace." Particularly recognised is an organisation's commitment to its most important assets - its workforce.
Jane Balmain, Managing Director of Companion Care Vets said: "We value every member of our team who have all worked tirelessly over the past 11 years to help our expansion into the market leader we are today. Without the commitment and expertise of every person within the organisation this would not have been possible and for us to receive this recognition, and on our first try, is outstanding."
Jane added: "To be the first veterinary organisation to receive Best Companies Accreditation is an honour and we will strive to continue to provide an exceptional working environment for our teams."
As part of the survey process 79% of Companion Care Vets' employees said their jobs are good for personal growth, 76% felt their jobs were secure and a fantastic 81% said colleagues are committed to taking care of each other.
With 109 Joint Veterinary Partners and a further 867 employees in the group, Companion Care Vets is one of the largest veterinary employers in the UK. The company plans to have 200 surgeries in place by 2015 which will create a host of career opportunities for vets and veterinary support teams around the UK.
Ceva introduced eco-friendly CLAS (Ceva Layered Anti Shatter) vials in 2007 and continues to invest in the technology for livestock injectables, such as NSAIDs and antibiotics.
However, the three-minute survey - https://www.surveymonkey.co.uk/r/CLASvials - will help it better understand current attitudes towards packaging and how it can continue to make changes that will drive improvements across the industry.
Five participating vets’ names will be picked at random to win a £20 Amazon voucher in a prize draw.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: “Following discussions with both UK vets and farmers, we believe that there is some confusion around the disposal of pharmaceutical waste both on farm and from the vet clinic.
"The survey will give us an insight into what is happening to pharmaceutical waste on farms and help us to drive improvements across the industry.”
Founded in 1922, the practice has come a long way from the days when its founder, Tom Patterson did his rounds on a motorbike with a sidecar.
It's now a successful farm and small animal two branch practice with over 60 staff.
To celebrate its centenary, Shepton Vets published a book called '100 years of Shepton Vets' and held a large summer party.
In September, the practice will be holding a 100km fundraising cycle ride to raise money for the Farming Community Network charity.
The farm animal practice has also organised the ‘Tour de Yorkshire,’ a trip to visit three farms based in Yorkshire who are modernising and adapting their dairy businesses to be resilient and successful in the changing industry.
Senior director, Paddy Gordon, said: “Turning one hundred is important. We may have grown substantially but we haven’t lost the family and community feel. We want to bring our community, near and far along with us on this celebration.”
It may not be quite the same as a telegram from the Queen, but VetSurgeon.org wishes Shepton Vets a very Happy Birthday!
Open to everyone in the profession, Congress '24 will include over 130 hours of CPD across 32 different modules covering topics such as advanced diabetes, dermatology, nursing clinics, EDI and more.
The programme format caters to a variety of learning styles, from lectures and panel discussions to interactive sessions and free CPD workshops.
There'll be over 120 exhibitors in three commercial exhibition, offering insights into some of the latest industry innovations, from pharmaceuticals to cutting-edge equipment.
Andy Green, Chair of the Congress Committee said: "We know it's a significant commitment for individuals to give up one to three days, plus travel time, to join us, and we don't just aim to educate; we want our attendees to enjoy the experience.
"Our aspiration is not just to meet their expectations but to exceed them.
"The veterinary profession faces challenges, but we have so much to celebrate, and what better place to come together with many like-minded individuals to remind yourself why you wanted to be in this profession in the first place."
Early bird registration is open until 31st January, and prices start at £93 +VAT for BSAVA members for a one-day pass.
www.bsavacongress.com
BCF, the veterinary imaging company, has launched a competition in which you can test your knowledge on a series of x-ray and ultrasound images for the chance to win a Sony Cyber Shot digital camera.
Visit the BCF website to enter - www.bcftechnology.com/
Entries to be in by 31st May 2011 and the winner will be drawn at random on the 6th of June 2011.
The RCVS has clarified its role concerning new UK veterinary schools, saying that it has no mandate to control student or graduate numbers.
Responding to calls from the profession that it should comment on the desirability of any change in the number of schools or graduates, the College has confirmed that whilst it is committed to setting, upholding and advancing the standards that any new UK veterinary degrees would need to meet in order to be approved by the Privy Council, it has no role in capping student numbers.
The College also points out that the free market and mobility of workers in the EU makes any control at the level of a sovereign state effectively meaningless with respect to workforce management. However, the College says it is committed to ensuring that standards are maintained, and to continue working with bodies such as the European Association of Establishments for Veterinary Education, which evaluates veterinary degrees across Europe.
The College also seeks to support healthy debate through providing information on the state of the profession - an example of which is the survey that it recently commissioned from the Institute for Employment Studies on job availability for veterinary graduates over the last five years.
The headline results from that survey were released in the summer, and showed that increasing graduate numbers over the last five years have so far appeared to have had little impact on veterinary job prospects, with 94% of graduate respondents seeking a role in clinical practice obtaining work within six months of starting to look.
The full RCVS Survey of Recent Graduates report is now available, and also shows that, of the 43% of veterinary surgeons who graduated in the last five years who responded:
The answers were analysed by year of graduation, veterinary school, age and gender, and the full report is available online at www.rcvs.org.uk/publications.
Locum vets Cristiana and Marco Tudini have had the holiday of a lifetime after winning a competition run by the recruitment consultants, Recruit4vets.
The couple, who came to the UK in 2006, were amongst 1000 people who entered the draw last year, when Cristiana was working for Companion Care in Folkestone.
Kelly Worrall from Recruit4vets said: "Our team called Cristiana on a typical day in the practice to deliver the news. She was obviously thrilled to get the call. Not only did we help find Cristiana her dream job, we sent her on a dream holiday too!"
Cristiana said: "My husband and I went to New York at the beginning of December. New York was full of festivities and was magical to go around Christmas time, we even visited Rockefeller Centre and watched the lights and singers. My husband and I are vegan, so we were delighted to find NYC filled with vegan restaurants and fast food outlets, we didn’t stop eating the whole trip!
"New York City was absolutely amazing, this really was a dream come true!"
Vetoquinol has launched Rimifin® a non-steroidal anti-inflammatory drug (NSAID) for dogs, containing carprofen. Carprofen can reduce inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. It can also be used as a follow-up to parenteral analgesia in the management of post-operative pain following soft tissue surgery. Rimifin® is available in a range of tablet sizes, 20mg, 50mg and 100mg. A single 100mg tablet can treat a 50kg dog.
MSD Animal Health has reintroduced Zanil, the flukicide drench for cattle and sheep.
Based on the active ingredient oxyclozanide, MSD says Zanil is highly effective against the adult fluke responsible for chronic disease and - significantly for dairy farmers - is licensed for use in young, pregnant and lactating animals, with a 72-hour milk withhold period where milk is produced for human consumption.
MSD Animal Health veterinary advisor Matt Haslam said: "The latest independent data1 confirms that fluke is on the increase in UK cattle and sheep. The fluke problem is longstanding, but is being exacerbated by recent wet summer and autumn periods that have created ideal conditions for this parasite to proliferate and infect grazing livestock.
"Chronic liver fluke causes serious economic losses for livestock farmers. In dairy herds, for example, there will be a negative impact on fertility and milk production where cows are affected.
"It is important that farmers have access to the best treatment options given the size of the threat and the scale of potential losses. Zanil is used widely and effectively in Ireland in the control of fluke problems, and there is no known resistance to the active ingredient oxyclozanide. With its re-introduction into the country, we believe Zanil is unique as a flukicide-only treatment that is licensed for use in lactation and in the dry period for the treatment of adult fluke in dairy cows."
Zanil is an oral drench with POM-VPS authorisation, available from both animal health suppliers and veterinary practices. Dosage rate is 3ml per 10kg bodyweight in cattle, up to a maximum of 105ml, and 4.5ml per 10kg bodyweight in sheep, up to a maximum of 20ml.
Reference
See DEFRA emerging threats reports in sheep and cattle, Q1 2013: www.defra.gov.uk/ahvla-en/files/pub-survrep-sr0113.pdf
The RCVS is seeking the views of veterinary surgeons, veterinary nurses and members of the public about proposals for a new Royal Charter which would clarify and underpin the role of the College and give it formal recognition as regulator of the veterinary nursing profession.
The new Charter, approved at a meeting of RCVS Council in November, would replace the 1967 Supplemental Charter, with the most far reaching change being a proposal to make veterinary nursing a formally regulated profession on a similar footing to veterinary surgeons. Veterinary nurses would become associates of the College and have the post-nominal letters RVN. The List and the Register of Veterinary Nurses would also be effectively combined, meaning that the 1,100 listed veterinary nurses would join the 10,500 already on the Register.
Under the proposals registered veterinary nurses would continue to need to fulfil certain responsibilities, including abiding by the Code of Professional Conduct and completing an average of 15 hours a year of continuing professional development, and would be subject to RCVS disciplinary procedures.
What's new is that individuals struck off from the Register for serious professional misconduct would no longer be able to give medical treatment or carry out minor surgery under veterinary direction.
As well as changes to the regulation of veterinary nursing, the proposed Charter would also more clearly state the role and remit of the RCVS, for example, in advancing standards through the promotion of continuing professional development and the Practice Standards Scheme.
Professor Stephen May, a member of RCVS Council who led the Legislation Working Party that developed the new Charter proposals, said: "The proposed new Charter represents an historic opportunity to affirm the role of the RCVS, and to provide a modern framework for the future regulation of the professions. I call on veterinary surgeons and nurses, together with other interested stakeholders, to read the consultation documents and support our proposals."
Speaking about the need for change, RCVS President Neil Smith added: "The consultation paper explains why it is time to replace the 1967 Charter with a new version which sets out the role of the College. The present Charter doesn't explain what objects the RCVS should set out to achieve, and it is silent about veterinary nurses. The remit of the College should include being the regulator for the veterinary nursing profession, and we want a new Charter to recognise registered veterinary nurses.
"We hope that the new Charter will provide a solid basis for the work of the College for years to come. We would urge members of the professions and the public to let us know what they think and help us to make sure that we have got it right."
The consultation paper, which contains further details about the proposed Charter, is available to download at www.rcvs.org.uk/consultations. Those who wish to have their say must respond to b.myring@rcvs.org.uk with their comments by Friday 7 February 2014.
The RCVS will also be organising a meeting and a webinar during the consultation period for those who wish to ask questions about the proposals. Those interested in attending a meeting should email b.myring@rcvs.org.uk. The webinar will be held early in 2014 - further details will be on www.rcvs.org.uk in due course.
The veterinary buying groups VetShare and London Vet Forum (LVF) have announced that they have merged to become the VetShare Buying Group.
VetShare Buying Group says that merger will ensure it has the resources and capabilities to compete in an industry that is increasingly made up of larger merged animal health suppliers.
The venture was prompted by a decision by London Vet Forum to offer itself up for a merger or sale with the aim of attracting better discounts for its members. It then interviewed a shortlist of candidates and says VetShare come out on top principally for its clarity and competitive discounts negotiated with the manufacturers.
In addition, VetShare and LVF shared some ways of working - members handle their own wholesaler invoice with the wholesaler-practice relationship remaining intact, allowing discounts to be rebated as a separate transaction. This means that members can continue to do business as before, while also benefiting from being part of the new, larger buying group.
Vet Ruth Gray, VetShare Director, said: "We are very pleased to have been chosen by the LVF directors to take their members into the future. We are the only major buying group without reps on the road and yet are now perhaps the largest buying group in the UK. We started VetShare initially to help our own practice achieve better discounts with the assumption that if we set up the perfect model for us then it would probably also be perfect for others. In hindsight, I think our assumption was right and this merger will mean even better discounts with new and exciting opportunities for existing members of both groups".
For more information on membership and the merged group, visit www.vetshare.co.uk or call Ruth on 0800 7566636.
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
The Department for Environment, Food and Rural Affairs (Defra) says this is evidence that its strategy to tackle bovine TB, which costs taxpayers £100m a year, is delivering results.
Defra says that gaining OTF status for the low risk area, covering the north and east of England, would boost trade opportunities and mean some herds require less regular TB testing, reducing costs for farmers.
This would be the first time anywhere in England has enjoyed this status and the government says it is a key step in its 25-year plan for the whole of the UK to be TB-free by 2038.
Environment Secretary Andrea Leadsom said: "Gaining global recognition that more than half of England is TB-free will be a significant milestone in our long-term plan to eradicate this devastating disease, and will open up new trading opportunities for farmers.
"We have much still to do in the worst affected parts of the country, but this shows that our strategy - combining practical biosecurity measures, a robust cattle movement and testing regime, and badger control in areas where the disease is rife - is right and is working."
Results published today confirm all ten licensed badger control operations achieved successful outcomes. A consultation opens today on next steps for badger control in areas that have completed the first four years of intensive culling.
Other measures announced today include:
Chief Veterinary Officer Nigel Gibbens said: "This year we have seen that badger control can be delivered successfully on a wider scale. Further expansion in the coming years, alongside our robust cattle movement and testing regime, will allow us to achieve and maintain long term reductions in the level of TB across the South West and Midlands where the disease is currently widespread."
The government says it is taking robust action to make the country TB-free by 2038, with a strategy including stronger cattle testing and movement controls, good biosecurity, badger control in areas where TB is rife and vaccination when possible.
Vaccinating healthy badgers is part of the government’s long-term plan and could play an important role in preventing bovine TB spreading to new areas of the country. Defra plans to resume the Badger Edge Vaccination Scheme, which offers support for private badger vaccination projects in edge area counties, in 2018 when we expect vaccine supplies to be available once more following the current global shortage.
The government is also supporting farmers to take practical action to reduce the risk of infection onto their farm. This includes support for a new CHeCS TB cattle herd accreditation scheme, on-farm biosecurity demonstrations for farmers, and training for veterinary surgeons delivered by APHA jointly with the private sector. Farmers can also access practical guidance on the TB Hub, which brings advice from farming experts, vets and government together in one place.
The webinar programme includes both clinical and non-clinical topics.
Clinical topics include post mortem/diagnostics and calf pneumonia, parasitology – getting the basics right, and herd health planning – vaccination on farm.
Non-clinical topics include business skills, motivational interviewing techniques – facilitating effective communication between farmers and vets, and cow signals.
Webinars take place on the last Wednesday of each month, except August and December when there are no sessions.
Each webinar lasts for one hour, including a live question and answer session with the presenter. Those who are unable to view the live webinar will be able to access the content at a later date, but will not be able to pose questions.
To access the webinars, you need to register on Merial’s Nexus portal (merialnexus.co.uk). If you sign up in advance for individual webinars, you'll get reminder emails before they start.
Two new edition's of Veterinary Focus, Royal Canin's free journal for companion animal veterinary surgeons are now available free of charge to UK vets.
Focus on Respiratory Disease includes features on brachycephalic syndrome, feline asthma, thoracic radiography of respiratory cases, canine fungal rhinitis, tracheobronchial foreign bodies in dogs and cats, emergency care of patients with acute respiratory distress, and respiratory parasitic diseases. Contributors include representatives from veterinary universities in Germany, Spain, Italy, the USA, and Argentina, and from the UK, Martin Sullivan BVMS, PhD, DVR, Dipl. ECVDI, MRCVS from Glasgow University and Mike Stafford Johnson, MVB, MRCVS, DVC Cert, SAM, MACVS from the Veterinary Cardiorespiratory Centre in Kenilworth.
Focus on Liver Disease includes features on feline inflammatory liver disease, canine portosystemic shunts, jaundice in the dog, extra-hepatic biliary system surgery, laboratory tests for liver disease, liver enzyme testing, diagnosis and treatment of liver tumours, and liver biopsy sampling. Contributors include representatives from veterinary universities in France, Spain, Italy, the USA, New Caledonia, Argentina, and Grenada, and from the Faculty of Veterinary Medicine, University of Edinburgh, Danielle Gunn-Moore, BSc. BVM&S, PhD, FHEA, MACVSc, MRCVS, Nicki Reed, BM&S, Cert VR.DSAM (Feline) Dipl. ECVIM-CA, MRCVS, and Kathryn Pratschke, MVB. MVM, Cert SAS, Dipl. ECVS, MRCVS.
Lee Danks, Royal Canin Veterinary Support manager, said: "Focus is a really interesting and informative publication, and with each issue focusing on a particular body system it offers a complete review of the latest thinking in each area. The contributors are all highly renowned in their individual fields, and being able to provide this kind of expertise to our veterinary partners is something we are really proud of."
Veterinary Focus is published in English, French, German, Chinese, Italian, Polish, Portuguese, Spanish, Japanese, Greek and Russian and reaches over 80,000 veterinary surgeons worldwide.
For a free copy of Focus, speak to your Royal Canin veterinary business manager, who will add you to the subscription list.
A new animal welfare report by the PDSA has revealed that millions of pets are more aggressive, overweight and misunderstood than ever due to fundamental gaps in pet owners' animal welfare knowledge.
The PDSA Animal Wellbeing (PAW) report, which captures the views of pet owners, the veterinary profession and children, reveals that 1.3 million dogs across the UK are displaying problem behaviour. It also highlights the consequences of an obesity epidemic affecting 18.5 million dogs, cats and rabbits, and draws attention to the 11.2 million pets not registered with a vet and therefore at risk of disease due to not being vaccinated or neutered.
The BVA is urging veterinary surgeons and nurses to read the report which identifies where owners are misinformed or unaware and highlights areas that everyone can work on with their clients to help achieve better wellbeing for pets.
Peter Jones, President of the BVA, said: "This is another excellent report from the PDSA offering real insight into clients' motivations. Understanding what drives owners' attitudes, as well as helping them to understand key health and welfare issues, should help us to clarify misconceptions in the consulting room and hopefully change behaviour at home.
"On the positive side, with pet obesity ever rising it is good to see that there is a slight increase in the proportion of owners starting to recognise obesity in their pets. This is, no doubt, in part due to the tireless work of charities like the PDSA and the veterinary profession as a whole.
"Sadly, despite most owners' awareness of the ill effect that bad nutrition has on their pet this has not led to them cutting out pet treats. The fact that few can identify a healthy body shape shows that much remains to be done.
"The section on preventive healthcare remains worrying with many owners seemingly not believing in the concepts of microchipping, neutering and vaccination. Vets have a real responsibility to help communicate these issues to the pet owning public for the benefit of both clients and their animals.
"The report very clearly identifies where owners are misinformed or unaware and highlights areas that vets in practice can work on with their clients to help achieve better wellbeing for pets.
"The report is very clearly laid out and well worth a read. We would encourage all vets to take a look and identify any new educational resources to promote in the practice, in newsletters and on websites in addition to the ones they already make available to clients. The AWF leaflets, the PDSA's own website, and the Education Alliance are all good starting points."
Click here for the report.
Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.
The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.
In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.1
A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.2
While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.3
While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.4
Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”
The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr
References
For the study, titled “RHDV2 epidemic in UK pet rabbits. Part 1: clinical features, gross post mortem and histopathological findings”1, veterinary surgeons were encouraged to submit case histories and the results of post mortem examinations of pet rabbits that died suddenly. Samples taken during the post mortem were sent for histopathological examination.
Frances Harcourt-Brown, corresponding author for the paper, said: "Case histories, macroscopic findings and histopathology results were available from 300 rabbits that died suddenly.
"Of these, 185 (62%) died from RHD and showed characteristic histopathological features of RHD including apoptosis and variable lytic and coagulative hepatocellular necrosis, with varying distribution.
"Interestingly, macroscopic evidence of disease was not present in all cases – for example, gross liver abnormalities were only reported in 30% of cases, despite all cases showing hepatocellular necrosis on microscopic examination.
"Rapid death and death of other rabbits in the household were common features of RHD.
"Histopathology was also useful in yielding valuable information about other causes of death in the rabbits that did not die from RHD.”
Nicola Di Girolamo, editor of JSAP said: “This is a terrible disease that is currently spreading in areas of the world that were free from it until recently. Having more evidence on the type of clinical presentations and lesions that should be expected with this disease in rabbit patients is going to be of tremendous value for clinicians. Given that there is not always macroscopic evidence of RHD, histopathology is key for the diagnosis of RHD in pet rabbits.”
The full article can be found in the July issue of the Journal of Small Animal Practice which is free for BSAVA members.
It can also be read online here: https://www.onlinelibrary.wiley.com/doi/full/10.1111/jsap.13141
Photo: BSAVA